Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Aehr Test Systems receives $4.3M order for initial FOX-XP test cell » 07:31
12/03/20
12/03
07:31
12/03/20
07:31
AEHR

Aehr Test Systems

$1.62 /

-0.04 (-2.41%)

Aehr Test Systems…

Aehr Test Systems announced it has received an initial $4.3M order from a new customer that is a supplier of sensors to a major mobile device manufacturer consisting of a FOX-XP production test and burn-in system, a set of DiePak Carriers, and a FOX Automated DiePak loader / unloader for a new high-volume application for production test and burn-in of mobile sensors. Shipment of the initial test cell is expected during Aehr's fiscal third quarter ending February 2021. Aehr expects follow-on capacity orders from this customer later in the current fiscal year for additional test systems, DiePaks, and DiePak loaders.

ShowHide Related Items >><<
AEHR Aehr Test Systems
$1.62 /

-0.04 (-2.41%)

AEHR Aehr Test Systems
$1.62 /

-0.04 (-2.41%)

Over a week ago
Hot Stocks
Aehr Test Systems receives initial order for FOX-XP DiePak Carriers » 08:50
11/05/20
11/05
08:50
11/05/20
08:50
AEHR

Aehr Test Systems

$1.19 /

+ (+0.00%)

Aehr Test System…

Aehr Test System announced a design win and an initial order for multiple DiePak Carriers for test and burn-in of its lead customer's next generation 3D sensor modules for mobile devices. The customer will use these Aehr proprietary DiePaks for production qualification, test, and burn-in of these devices prior to volume production orders for additional DiePaks forecasted for later in Aehr's current fiscal year.

ShowHide Related Items >><<
AEHR Aehr Test Systems
$1.19 /

+ (+0.00%)

AEHR Aehr Test Systems
$1.19 /

+ (+0.00%)

Over a month ago
Earnings
Aehr Test Systems backs FY21 revenue view $25M-$28M » 16:18
09/24/20
09/24
16:18
09/24/20
16:18
AEHR

Aehr Test Systems

$1.45 /

-0.015 (-1.02%)

For the fiscal year…

For the fiscal year ending May 31, 2021, Aehr maintains its expected full year total revenue to be between $25 million and $28 million, which would represent growth between 12% and 26% year over year, and to be profitable for the fiscal year.

ShowHide Related Items >><<
AEHR Aehr Test Systems
$1.45 /

-0.015 (-1.02%)

AEHR Aehr Test Systems
$1.45 /

-0.015 (-1.02%)

AEHR Aehr Test Systems
$1.45 /

-0.015 (-1.02%)

Earnings
Aehr Test Systems reports Q1 EPS (9c ), versus (1c) in Q119 » 16:10
09/24/20
09/24
16:10
09/24/20
16:10
AEHR

Aehr Test Systems

$1.47 /

+0.005 (+0.34%)

Reports Q1 revenue $2.01M…

Reports Q1 revenue $2.01M versus $5.5M in same quarter last year. We saw our silicon photonics customers move to production with our FOX systems for the first time this past fiscal 2020, which includes our lead customer and three additional silicon photonics customers who have each told us that they expect to ramp production during Aehr's fiscal 2021, adding capacity in both systems and consumables. During the quarter we shipped and installed a FOX-NP TM system for initial production burn-in and stabilization for a new customer in the silicon photonics space who is also forecasting to transition to our FOX-XP wafer-level test and burn-in systems during this fiscal year to meet their volume production forecast. "We continue to see the total available opportunity for silicon carbide and silicon photonics wafer level and singulated die test markets to be approximately $250 million of needed capacity including consumables. We are currently engaged with over a dozen potential Tier 1 and Tier 2 customers for both silicon photonics and silicon carbide applications, and we expect several of these potential customers to place initial orders this fiscal year, with ramps into production later this fiscal year or in fiscal 2022. We are also seeing renewed activity and interest for our FOX systems and consumables for several new applications in the 2D and 3D sensor markets, particularly for mobile devices, and believe this could add to our currently forecasted revenue for this fiscal year and next.

ShowHide Related Items >><<
AEHR Aehr Test Systems
$1.47 /

+0.005 (+0.34%)

AEHR Aehr Test Systems
$1.47 /

+0.005 (+0.34%)

AEHR Aehr Test Systems
$1.47 /

+0.005 (+0.34%)

Hot Stocks
Aehr Test Systems appoints Geoff Scott to board of directors » 07:43
09/09/20
09/09
07:43
09/09/20
07:43
AEHR

Aehr Test Systems

$1.80 /

+0.03 (+1.69%)

Aehr Test Systems…

Aehr Test Systems announced it has appointed Geoff Scott to its board of directors, effective September 2, 2020. The Company also announced John Schneider, who has served on the Aehr Test Systems board since 2014, has resigned for personal reasons effective September 2, 2020. The number of Aehr Test board members remains at six. Scott has been President of Scott Asset Management, whose clients invest primarily in small cap but industry leading companies.

ShowHide Related Items >><<
AEHR Aehr Test Systems
$1.80 /

+0.03 (+1.69%)

AEHR Aehr Test Systems
$1.80 /

+0.03 (+1.69%)

AEHR Aehr Test Systems
$1.80 /

+0.03 (+1.69%)

Over a quarter ago
Hot Stocks
Aehr Test Systems receives initial order for FOX-NP solution » 07:41
05/19/20
05/19
07:41
05/19/20
07:41
AEHR

Aehr Test Systems

$1.50 /

+0.01 (+0.67%)

Aehr Test Systems…

Aehr Test Systems announced it has received orders from a new customer and their subcontract manufacturing supplier for a FOX solution including a FOX-NP full wafer test system, an initial WaferPak Contactor, and a FOX WaferPak Aligner to perform production qualification of their silicon photonics devices. The total solution, including the FOX-NP system, WaferPak Aligner, and WaferPak Contactor, is expected to ship prior to the end of Aehr's next fiscal quarter ending August 31, 2020. This new customer will begin utilizing Aehr's FOX-NP system for initial production burn-in and stabilization of their high performance silicon photonic devices and is then expected to transition to Aehr's FOX-XP wafer-level test and burn-in systems to meet their volume production forecast.

ShowHide Related Items >><<
AEHR Aehr Test Systems
$1.50 /

+0.01 (+0.67%)

AEHR Aehr Test Systems
$1.50 /

+0.01 (+0.67%)

AEHR Aehr Test Systems
$1.50 /

+0.01 (+0.67%)

On The Fly
Fly Intel: Wall Street's top stories for Friday » 16:30
04/03/20
04/03
16:30
04/03/20
16:30
MMM

3M

$133.90 /

-3.96 (-2.87%)

, TSLA

Tesla

$479.71 /

+25.715 (+5.66%)

, BBBY

Bed Bath & Beyond

$3.94 /

+0.385 (+10.83%)

, BAC

Bank of America

$20.03 /

-0.535 (-2.60%)

, JPM

JPMorgan

$84.08 /

-1.57 (-1.83%)

, WFC

Wells Fargo

$26.23 /

-0.98 (-3.60%)

, C

Citi

$37.48 /

-1.82 (-4.63%)

, AMZN

Amazon.com

$1,905.62 /

-11.4 (-0.59%)

, WMT

Walmart

$119.37 /

+0.74 (+0.62%)

, FATE

Fate Therapeutics

$22.94 /

+1.87 (+8.88%)

, JNJ

Johnson & Johnson

$134.13 /

+1.05 (+0.79%)

, INCY

Incyte

$78.69 /

+1.68 (+2.18%)

, MIC

Macquarie Infrastructure

$18.23 /

-5.79 (-24.10%)

, AEHR

Aehr Test Systems

$1.27 /

-0.36 (-22.09%)

, CHWY

Chewy

$33.27 /

-1.995 (-5.66%)

The S&P 500 ended lower…

ShowHide Related Items >><<
MMM 3M
$133.90 /

-3.96 (-2.87%)

03/30/20
Fly Intel: Top five analyst downgrades
03/30/20 Gordon Haskett
3M downgraded to Underperform from Hold at Gordon Haskett
01/09/20 Wolfe Research
3M upgraded to Peer Perform from Underperform at Wolfe Research
12/23/19
Fly Intel: Top five analyst actions
TSLA Tesla
$479.71 /

+25.715 (+5.66%)

04/06/20 Jefferies
Tesla upgraded to Buy from Hold at Jefferies
04/03/20 GLJ Research
Tesla deliveries 'exact opposite' of growth company, says GLJ Research
04/03/20 Cowen
Tesla unit deliveries not as bad as feared, says Cowen
04/03/20 Oppenheimer
Tesla's Q1 deliveries better than feared, says Oppenheimer
BBBY Bed Bath & Beyond
$3.94 /

+0.385 (+10.83%)

03/23/20 Odeon Capital
Bed Bath & Beyond downgraded to Hold from Buy at Odeon Capital
03/23/20 Telsey Advisory
Bed Bath & Beyond downgraded to Market Perform from Outperform at Telsey Advisory
03/20/20 KeyBanc
Bed Bath & Beyond turnaround to take longer than expected, says KeyBanc
03/20/20 KeyBanc
Bed Bath & Beyond downgraded to Sector Weight from Overweight at KeyBanc
BAC Bank of America
$20.03 /

-0.535 (-2.60%)

04/06/20 Wells Fargo
Wells Fargo sees information 'void' until banks report earnings next week
04/02/20 DA Davidson
DA Davidson upgraded Bank of America to Buy from Neutral
04/02/20 DA Davidson
Bank of America upgraded to Buy from Neutral at DA Davidson
03/30/20 Credit Suisse
Bank of America price target lowered to $31 from $39 at Credit Suisse
JPM JPMorgan
$84.08 /

-1.57 (-1.83%)

04/01/20 Keefe Bruyette
Keefe Bruyette upgrades JPMorgan, downgrades Citi into expected recession
04/01/20 Keefe Bruyette
JPMorgan upgraded to Outperform from Market Perform at Keefe Bruyette
03/27/20 BofA
JPMorgan downgraded to Neutral from Buy at BofA
WFC Wells Fargo
$26.23 /

-0.98 (-3.60%)

03/26/20 Odeon Capital
Wells Fargo upgraded to Hold from Sell at Odeon Capital
03/26/20 Berenberg
Wells Fargo upgraded to Hold from Sell at Berenberg
02/28/20
Fly Intel: Top five analyst upgrades
02/28/20 Atlantic Equities
Wells Fargo upgraded to Neutral from Underweight at Atlantic Equities
C Citi
$37.48 /

-1.82 (-4.63%)

04/01/20 Keefe Bruyette
Citi downgraded to Market Perform from Outperform at Keefe Bruyette
02/28/20 Wells Fargo
Wells Fargo cuts large-cap bank estimates, but notes balance sheet strength
AMZN Amazon.com
$1,905.62 /

-11.4 (-0.59%)

04/06/20 Raymond James
Spotify double downgraded to Market Perform at Raymond James
03/26/20 Deutsche Bank
Amazon.com price target lowered to $2,300 from $2,400 at Deutsche Bank
03/20/20 Oppenheimer
Amazon likely seeing 'record' consumer demand, says Oppenheimer
03/18/20 Baird
FedEx risk/reward very compelling at current levels, says at Baird
WMT Walmart
$119.37 /

+0.74 (+0.62%)

03/31/20
Fly Intel: Top five analyst initiations
03/31/20 Wolfe Research
Walmart initiated with an Outperform at Wolfe Research
03/26/20
Fly Intel: Top five analyst initiations
03/26/20 Atlantic Equities
Walmart initiated with an Overweight at Atlantic Equities
FATE Fate Therapeutics
$22.94 /

+1.87 (+8.88%)

04/02/20 Piper Sandler
Fate Therapeutics price target raised to $63 from $57 at Piper Sandler
03/04/20 Barclays
Barclays starts small, mid cap Biotechnology sector with Positive view
03/04/20 Citi
Fate Therapeutics price target raised to $41 from $26 at Citi
03/04/20 Barclays
Fate Therapeutics initiated with an Overweight at Barclays
JNJ Johnson & Johnson
$134.13 /

+1.05 (+0.79%)

04/02/20 Wells Fargo
Johnson & Johnson price target lowered to $150 from $165 at Wells Fargo
03/24/20 SVB Leerink
Arrowhead upgraded to Market Perform at SVB Leerink on more balanced risk/reward
03/18/20 Cantor Fitzgerald
Cantor Fitzgerald says J&J is top idea in large cap pharma space
03/11/20 H.C. Wainwright
H.C. Wainwright reiterates Buy on Genmab following J&J drug announcement
INCY Incyte
$78.69 /

+1.68 (+2.18%)

04/01/20 Morgan Stanley
Incyte upgraded to Overweight on underappreciated pipeline at Morgan Stanley
04/01/20 Morgan Stanley
Incyte upgraded to Overweight from Equal Weight at Morgan Stanley
03/25/20 Oppenheimer
Incyte price target lowered to $85 from $99 at Oppenheimer
03/24/20 William Blair
Incyte resumed with an Outperform at William Blair
MIC Macquarie Infrastructure
$18.23 /

-5.79 (-24.10%)

04/03/20 RBC Capital
Macquarie Infrastructure cut to Sector Perform from Outperform at RBC Capital
03/25/20 RBC Capital
Macquarie Infrastructure upgraded to Outperform from Sector Perform at RBC
01/09/20 Wells Fargo
Macquarie Infrastructure upgraded to Overweight at Wells Fargo
01/08/20 Wells Fargo
Macquarie Infrastructure upgraded to Overweight from Equal Weight at Wells Fargo
AEHR Aehr Test Systems
$1.27 /

-0.36 (-22.09%)

CHWY Chewy
$33.27 /

-1.995 (-5.66%)

04/03/20 Nomura
Chewy price target raised to $40 from $36 at Nomura Instinet
03/30/20 Barclays
Chewy price target raised to $33 from $30 at Barclays
02/24/20 Sidoti
PetMed Express downgraded to Neutral from Buy at Sidoti
02/24/20 Evercore ISI
Chewy initiated with an Outperform at Evercore ISI
On The Fly
Fly Intel: Wall Street's top stories at midday » 12:28
04/03/20
04/03
12:28
04/03/20
12:28
MMM

3M

$133.94 /

-3.92 (-2.84%)

, TSLA

Tesla

$480.37 /

+26.38 (+5.81%)

, JPM

JPMorgan

$83.84 /

-1.81 (-2.11%)

, BAC

Bank of America

$19.78 /

-0.785 (-3.82%)

, C

Citi

$37.30 /

-2 (-5.09%)

, GS

Goldman Sachs

$145.44 /

-4.5 (-3.00%)

, MS

Morgan Stanley

$33.05 /

-0.84 (-2.48%)

, USB

U.S. Bancorp

$31.42 /

-1.29 (-3.94%)

, WFC

Wells Fargo

$26.11 /

-1.1 (-4.04%)

, BBBY

Bed Bath & Beyond

$3.53 /

-0.025 (-0.70%)

, FATE

Fate Therapeutics

$23.38 /

+2.31 (+10.96%)

, JNJ

Johnson & Johnson

$132.93 /

-0.15 (-0.11%)

, INCY

Incyte

$78.37 /

+1.36 (+1.77%)

, MIC

Macquarie Infrastructure

$17.68 /

-6.34 (-26.39%)

, AEHR

Aehr Test Systems

$1.38 /

-0.25 (-15.34%)

, CHWY

Chewy

$33.61 /

-1.655 (-4.69%)

The S&P and Dow are…

ShowHide Related Items >><<
MMM 3M
$133.94 /

-3.92 (-2.84%)

03/30/20
Fly Intel: Top five analyst downgrades
03/30/20 Gordon Haskett
3M downgraded to Underperform from Hold at Gordon Haskett
01/09/20 Wolfe Research
3M upgraded to Peer Perform from Underperform at Wolfe Research
12/23/19
Fly Intel: Top five analyst actions
TSLA Tesla
$480.37 /

+26.38 (+5.81%)

04/03/20 GLJ Research
Tesla deliveries 'exact opposite' of growth company, says GLJ Research
04/03/20 Cowen
Tesla unit deliveries not as bad as feared, says Cowen
04/03/20 Oppenheimer
Tesla's Q1 deliveries better than feared, says Oppenheimer
04/03/20 Wedbush
Tesla's Q1 delivery numbers 'a small victory in dark environment,' says Wedbush
JPM JPMorgan
$83.84 /

-1.81 (-2.11%)

04/01/20 Keefe Bruyette
Keefe Bruyette upgrades JPMorgan, downgrades Citi into expected recession
04/01/20 Keefe Bruyette
JPMorgan upgraded to Outperform from Market Perform at Keefe Bruyette
03/27/20 BofA
JPMorgan downgraded to Neutral from Buy at BofA
03/27/20 BofA
JPMorgan downgraded to Neutral from Buy at BofA
BAC Bank of America
$19.78 /

-0.785 (-3.82%)

04/02/20 DA Davidson
DA Davidson upgraded Bank of America to Buy from Neutral
04/02/20 DA Davidson
Bank of America upgraded to Buy from Neutral at DA Davidson
03/30/20 Credit Suisse
Bank of America price target lowered to $31 from $39 at Credit Suisse
03/25/20 Wolfe Research
Bank of America downgraded to Peer Perform from Outperform at Wolfe Research
C Citi
$37.30 /

-2 (-5.09%)

04/01/20 Keefe Bruyette
Citi downgraded to Market Perform from Outperform at Keefe Bruyette
02/28/20 Wells Fargo
Wells Fargo cuts large-cap bank estimates, but notes balance sheet strength
02/03/20 Odeon Capital
Odeon's Bove upgrades JPMorgan, downgrades four other banks in defensive shift
GS Goldman Sachs
$145.44 /

-4.5 (-3.00%)

04/02/20 DA Davidson
Goldman Sachs downgraded to Neutral from Buy at DA Davidson
03/30/20 Citi
Goldman Sachs price target lowered to $245 from $260 at Citi
03/26/20 Berenberg
Goldman Sachs upgraded to Hold from Sell at Berenberg
03/16/20 Citi
Goldman Sachs price target lowered to $260 from $290 at Citi
MS Morgan Stanley
$33.05 /

-0.84 (-2.48%)

04/02/20 Credit Suisse
Morgan Stanley price target lowered to $46 from $60 at Credit Suisse
03/13/20 Goldman Sachs
Morgan Stanley upgraded to Buy from Neutral at Goldman Sachs
03/04/20
Fly Intel: Top five analyst upgrades
03/04/20 Citi
Citi upgrades Morgan Stanley to Buy on 'very attractive entry point'
USB U.S. Bancorp
$31.42 /

-1.29 (-3.94%)

04/01/20 Oppenheimer
U.S. Bancorp upgraded to Outperform with $57 price target at Oppenheimer
04/01/20 Oppenheimer
U.S. Bancorp upgraded to Outperform from Perform at Oppenheimer
03/17/20 Baird
Baird increasing bank exposure, upgrades names to Outperform
03/17/20 Baird
U.S. Bancorp upgraded to Outperform from Neutral at Baird
WFC Wells Fargo
$26.11 /

-1.1 (-4.04%)

03/26/20 Odeon Capital
Wells Fargo upgraded to Hold from Sell at Odeon Capital
03/26/20 Berenberg
Wells Fargo upgraded to Hold from Sell at Berenberg
02/28/20
Fly Intel: Top five analyst upgrades
02/28/20 Atlantic Equities
Wells Fargo upgraded to Neutral from Underweight at Atlantic Equities
BBBY Bed Bath & Beyond
$3.53 /

-0.025 (-0.70%)

03/23/20 Odeon Capital
Bed Bath & Beyond downgraded to Hold from Buy at Odeon Capital
03/23/20 Telsey Advisory
Bed Bath & Beyond downgraded to Market Perform from Outperform at Telsey Advisory
03/20/20 KeyBanc
Bed Bath & Beyond turnaround to take longer than expected, says KeyBanc
03/20/20 KeyBanc
Bed Bath & Beyond downgraded to Sector Weight from Overweight at KeyBanc
FATE Fate Therapeutics
$23.38 /

+2.31 (+10.96%)

04/02/20 Piper Sandler
Fate Therapeutics price target raised to $63 from $57 at Piper Sandler
03/04/20 Barclays
Barclays starts small, mid cap Biotechnology sector with Positive view
03/04/20 Citi
Fate Therapeutics price target raised to $41 from $26 at Citi
03/04/20 Barclays
Fate Therapeutics initiated with an Overweight at Barclays
JNJ Johnson & Johnson
$132.93 /

-0.15 (-0.11%)

04/02/20 Wells Fargo
Johnson & Johnson price target lowered to $150 from $165 at Wells Fargo
03/24/20 SVB Leerink
Arrowhead upgraded to Market Perform at SVB Leerink on more balanced risk/reward
03/18/20 Cantor Fitzgerald
Cantor Fitzgerald says J&J is top idea in large cap pharma space
03/11/20 H.C. Wainwright
H.C. Wainwright reiterates Buy on Genmab following J&J drug announcement
INCY Incyte
$78.37 /

+1.36 (+1.77%)

04/01/20 Morgan Stanley
Incyte upgraded to Overweight on underappreciated pipeline at Morgan Stanley
04/01/20 Morgan Stanley
Incyte upgraded to Overweight from Equal Weight at Morgan Stanley
03/25/20 Oppenheimer
Incyte price target lowered to $85 from $99 at Oppenheimer
03/24/20 William Blair
Incyte resumed with an Outperform at William Blair
MIC Macquarie Infrastructure
$17.68 /

-6.34 (-26.39%)

04/03/20 RBC Capital
Macquarie Infrastructure cut to Sector Perform from Outperform at RBC Capital
03/25/20 RBC Capital
Macquarie Infrastructure upgraded to Outperform from Sector Perform at RBC
01/09/20 Wells Fargo
Macquarie Infrastructure upgraded to Overweight at Wells Fargo
01/08/20 Wells Fargo
Macquarie Infrastructure upgraded to Overweight from Equal Weight at Wells Fargo
AEHR Aehr Test Systems
$1.38 /

-0.25 (-15.34%)

CHWY Chewy
$33.61 /

-1.655 (-4.69%)

04/03/20 Nomura
Chewy price target raised to $40 from $36 at Nomura Instinet
03/30/20 Barclays
Chewy price target raised to $33 from $30 at Barclays
02/24/20 Sidoti
PetMed Express downgraded to Neutral from Buy at Sidoti
02/24/20 Evercore ISI
Chewy initiated with an Outperform at Evercore ISI
On The Fly
Fly Intel: After-Hours Movers » 19:02
04/02/20
04/02
19:02
04/02/20
19:02
PLAY

Dave & Buster's

$10.04 /

-0.65 (-6.08%)

, FATE

Fate Therapeutics

$21.07 /

+0.865 (+4.28%)

, TSLA

Tesla

$453.99 /

-27.61 (-5.73%)

, ZUMZ

Zumiez

$14.55 /

-0.34 (-2.28%)

, INCY

Incyte

$77.01 /

+2.8 (+3.77%)

, BBBY

Bed Bath & Beyond

$3.56 /

-0.235 (-6.20%)

, PTON

Peloton

$26.73 /

-1.21 (-4.33%)

, CAKE

Cheesecake Factory

$15.11 /

-0.63 (-4.00%)

, AEHR

Aehr Test Systems

$1.63 /

+0.045 (+2.84%)

, CHWY

Chewy

$35.27 /

-0.575 (-1.60%)

, DTIL

Precision BioSciences

$5.53 /

+0.26 (+4.93%)

Check out this…

ShowHide Related Items >><<
PLAY Dave & Buster's
$10.04 /

-0.65 (-6.08%)

04/03/20 BMO Capital
Dave & Buster's downgraded to Market Perform from Outperform at BMO Capital
04/01/20 Truist
El Pollo Loco upgraded to Buy from Hold at SunTrust
03/17/20
Fly Intel: Top five analyst downgrades
03/17/20 Piper Sandler
Dave & Buster's downgraded to Neutral from Overweight at Piper Sandler
FATE Fate Therapeutics
$21.07 /

+0.865 (+4.28%)

04/02/20 Piper Sandler
Fate Therapeutics price target raised to $63 from $57 at Piper Sandler
03/04/20 Barclays
Barclays starts small, mid cap Biotechnology sector with Positive view
03/04/20 Citi
Fate Therapeutics price target raised to $41 from $26 at Citi
03/04/20 Barclays
Fate Therapeutics initiated with an Overweight at Barclays
TSLA Tesla
$453.99 /

-27.61 (-5.73%)

04/03/20 Wedbush
Tesla's Q1 delivery numbers 'a small victory in dark environment,' says Wedbush
04/03/20 JMP Securities
Tesla may be supply constrained in Q2, says JMP Securities
04/03/20 JPMorgan
Tesla beat Q1 deliveries, but Q2 'much more challenging,' says JPMorgan
04/01/20 Barclays
Barclays warns Tesla bears narrative 'could swing bullish' near-term
ZUMZ Zumiez
$14.55 /

-0.34 (-2.28%)

03/16/20 DA Davidson
Zumiez price target lowered to $20 from $33 at DA Davidson
03/13/20 Pivotal Research
Zumiez price target lowered to $21 from $26 at Pivotal Research
03/11/20 Wedbush
Zumiez upgraded to Neutral at Wedbush as recent selloff resets valuation
03/11/20 Wedbush
Zumiez upgraded to Neutral from Underperform at Wedbush
INCY Incyte
$77.01 /

+2.8 (+3.77%)

04/01/20 Morgan Stanley
Incyte upgraded to Overweight on underappreciated pipeline at Morgan Stanley
04/01/20 Morgan Stanley
Incyte upgraded to Overweight from Equal Weight at Morgan Stanley
03/25/20 Oppenheimer
Incyte price target lowered to $85 from $99 at Oppenheimer
03/24/20 William Blair
Incyte resumed with an Outperform at William Blair
BBBY Bed Bath & Beyond
$3.56 /

-0.235 (-6.20%)

03/23/20 Odeon Capital
Bed Bath & Beyond downgraded to Hold from Buy at Odeon Capital
03/23/20 Telsey Advisory
Bed Bath & Beyond downgraded to Market Perform from Outperform at Telsey Advisory
03/20/20 KeyBanc
Bed Bath & Beyond turnaround to take longer than expected, says KeyBanc
03/20/20 KeyBanc
Bed Bath & Beyond downgraded to Sector Weight from Overweight at KeyBanc
PTON Peloton
$26.73 /

-1.21 (-4.33%)

04/02/20 Rosenblatt
Rosenblatt starts 'fitness disruptor' Peloton at Buy with $42 target
04/02/20 Rosenblatt
Peloton initiated with a Buy at Rosenblatt
03/17/20 Wedbush
Peloton added to Best Ideas List at Wedbush
03/09/20 KeyBanc
KeyBanc notes more details on Peloton rival SoulCycle's at-home bike
CAKE Cheesecake Factory
$15.11 /

-0.63 (-4.00%)

03/31/20
upgraded Fly Intel: Top five analyst upgrades
03/31/20 Gordon Haskett
Cheesecake Factory upgraded to Buy after 60% selloff at Gordon Haskett
03/31/20 Gordon Haskett
Cheesecake Factory upgraded to Buy from Hold at Gordon Haskett
03/26/20 RBC Capital
Cheesecake, AMC news highlight tenants financial stress, says RBC Capital
AEHR Aehr Test Systems
$1.63 /

+0.045 (+2.84%)

CHWY Chewy
$35.27 /

-0.575 (-1.60%)

04/03/20 Nomura
Chewy price target raised to $40 from $36 at Nomura Instinet
03/30/20 Barclays
Chewy price target raised to $33 from $30 at Barclays
02/24/20 Sidoti
PetMed Express downgraded to Neutral from Buy at Sidoti
02/24/20 Evercore ISI
Chewy initiated with an Outperform at Evercore ISI
DTIL Precision BioSciences
$5.53 /

+0.26 (+4.93%)

04/02/20 Goldman Sachs
Precision BioSciences downgraded to Neutral from Buy at Goldman Sachs
04/02/20 Goldman Sachs
Precision BioSciences downgraded to Neutral from Buy at Goldman Sachs
03/04/20 Stifel
Precision BioSciences initiated with a Buy at Stifel
02/25/20 William Blair
Precision BioSciences initiated with an Outperform at William Blair
Earnings
Aehr Test Systems withdraws FY20 guidance » 16:09
04/02/20
04/02
16:09
04/02/20
16:09
AEHR

Aehr Test Systems

$1.59 /

+0.005 (+0.32%)

Aehr Test Systems CEO…

Aehr Test Systems CEO Gayn Erickson said, "Due to the uncertainty of the full impact of the COVID-19 pandemic on our customers, we simply cannot predict how this will impact our business in the near term and are taking the conservative stance to withdraw our previously provided guidance for the fiscal 2020 year ending May 31, 2020."

ShowHide Related Items >><<

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.